Moreover, Fujishiro et al. found that inhibiting CTGF by neutralizing the anti-CTGF monoclonal antibody (mAb) significantly ameliorated arthritis in a murine model of RA [13]. This evidence concerns the gene CCN2 and arthritic joint disease.